RSV
New ACIP Panel Votes to Recommend Clesrovimab, Second Antibody to Prevent RSV in Infants
The seven newly appointed members of ACIP voted 5-to-2 to recommend Enflonsia, the second long-acting monoclonal ...
JUNE 26, 2025
FDA Approves Enflonsia, Second RSV Antibody for Infants
The FDA has approved the second monoclonal antibody for the prevention of RSV in neonates and infants, ...
JUNE 10, 2025
Sanofi Accelerates Beyfortus Shipping Ahead of Next RSV Season
Sanofi said it would ship nirsevimab starting earlier to ensure broad availability well ahead of the 2025-2026 RSV ...
JUNE 9, 2025
Infant RSV Hospitalization Rates Dropped Significantly After Antibody, Vaccine Prevention Introduced
RSV-associated hospitalization in infants fell sharply during the first virus season after the introduction of ...
JUNE 5, 2025
Minimal Cocirculation Between hMPV and RSV
Cocirculation of human metapneumovirus and respiratory syncytial virus has been minimal in recent years, according ...
MAY 22, 2025
Minimal Cocirculation of hMPV and RSV Seen
Cocirculation of hMPV and RSV has been minimal in recent years, partly due to changes in RSV seasonality, which ...
MAY 21, 2025
Elevated Rates of Influenza-Associated Encephalopathy Seen Among Pediatric Flu Deaths
A newly released CDC report reveals that 13% of children who have died of influenza this season had ...
APRIL 30, 2025
New Test Launches to Detect Respiratory Pathogens in Wastewater
A new option will be available soon to test wastewater for potential infectious respiratory disease ...
APRIL 22, 2025
ACIP Recommends Expanded Use for RSV Vaccines
In a unanimous vote, the CDC’s Advisory Committee on Immunization Practices voted to expand its ...
APRIL 17, 2025
The Cutting Edge of Respiratory Diagnostics: An Ever-Evolving Laboratory Arsenal
This review aims to address all the myriad ways in which respiratory testing continues to evolve
FEBRUARY 28, 2025
Study Dispels Concerns Over AFib Risk After RSV Vaccine
Vaccination with either of the currently available RSV vaccines was not associated with an increased risk for AFib, ...
FEBRUARY 19, 2025
Moderna Pauses Pediatric RSV Vaccine Trial; FDA Needs More Data
More testing is needed to clarify results from Moderna’s paused clinical trial of the safety and efficacy of ...
FEBRUARY 14, 2025
